Literature DB >> 12652454

Chlamydia pneumoniae and atherosclerosis.

Lee Ann Campbell1, Cho-Chou Kuo.   

Abstract

Chlamydia pneumoniae is a human respiratory pathogen that causes acute respiratory disease. Multiple studies have associated C. pneumoniae with cardiovascular disease including seroepidemiologic studies, direct detection of the organism within the lesion, and isolation of the organism from atheromatous tissue. The most critical question to be answered by researchers in the field is whether C. pneumoniae plays a role in atherogenesis. This review summarizes in vitro studies, results in animal models of C. pneumoniae infection and atherogenesis, and human intervention studies that provide some support of a mechanistic role. Copyright 2003 Elsevier, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2003        PMID: 12652454     DOI: 10.1053/srin.2003.50006

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  20 in total

1.  Tarp and Arp: How Chlamydia induces its own entry.

Authors:  Joanne Engel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-29       Impact factor: 11.205

Review 2.  Amoebae as training grounds for intracellular bacterial pathogens.

Authors:  Maëlle Molmeret; Matthias Horn; Michael Wagner; Marina Santic; Yousef Abu Kwaik
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

3.  Drosophila melanogaster S2 cells: a model system to study Chlamydia interaction with host cells.

Authors:  C Elwell; J N Engel
Journal:  Cell Microbiol       Date:  2005-05       Impact factor: 3.715

4.  Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice.

Authors:  C Scott Little; Andrew Bowe; Richard Lin; Jason Litsky; Robert M Fogel; Brian J Balin; Kerin L Fresa-Dillon
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Impact of free-living amoebae on presence of Parachlamydia acanthamoebae in the hospital environment and its survival in vitro without requirement for amoebae.

Authors:  Tatsuya Fukumoto; Junji Matsuo; Yasuhiro Hayashi; Masahiro Hayashi; Satoshi Oguri; Shinji Nakamura; Yoshihiko Mizutani; Takashi Yao; Kouzi Akizawa; Haruki Suzuki; Chikara Shimizu; Kazuhiko Matsuno; Hiroyuki Yamaguchi
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

6.  Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis.

Authors:  Whitney Greene; Yangming Xiao; Yanqing Huang; Grant McClarty; Guangming Zhong
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene.

Authors:  Jae Dugan; Daniel D Rockey; Loren Jones; Arthur A Andersen
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

Review 8.  The role of complement activation in atherosclerosis.

Authors:  Florin Niculescu; Horea Rus
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

9.  Endosulfatases SULF1 and SULF2 limit Chlamydia muridarum infection.

Authors:  J H Kim; C Chan; C Elwell; M S Singer; T Dierks; H Lemjabbar-Alaoui; S D Rosen; J N Engel
Journal:  Cell Microbiol       Date:  2013-04-09       Impact factor: 3.715

10.  Novel Parachlamydia acanthamoebae quantification method based on coculture with amoebae.

Authors:  Junji Matsuo; Yasuhiro Hayashi; Shinji Nakamura; Marie Sato; Yoshihiko Mizutani; Masahiro Asaka; Hiroyuki Yamaguchi
Journal:  Appl Environ Microbiol       Date:  2008-08-29       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.